COVID-19: Current Trends in Invitro Diagnostics
| Autor: | Rhema Elizabeth Thomas, Ajaikumar Sukumaran, R. Arun Krishnan, Damodaran Vasudevan, Jofy K Paul |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clinical Biochemistry Review Article Disease medicine.disease_cause law.invention 03 medical and health sciences Loop mediated isothermal amplification 0302 clinical medicine Antigen Lateral flow immunoassay law Pandemic medicine Polymerase chain reaction Coronavirus SARS-CoV-2 Reverse transcriptase PCR business.industry Virology 030104 developmental biology 030220 oncology & carcinogenesis ELISA Viral disease CLIA business |
| Zdroj: | Indian Journal of Clinical Biochemistry |
| ISSN: | 0974-0422 0970-1915 |
| DOI: | 10.1007/s12291-020-00906-5 |
| Popis: | The novel coronavirus SARS-CoV-2 is the seventh known species of coronavirus, infectious to human beings. The pandemic COVID-19 spread all over the world with an unprecedented spreading rate after its first appearance in Wuhan, China. As a novel viral disease there in no antiviral treatment or vaccine for the COVID-19. At present, the early detection and the quarantine of infected patients are the ways to stop the spreading of the disease. This review will discuss about the current invitro diagnostic methods used worldwide for the early and accurate diagnosis of COVID-19. Currently the nucleic acid based polymerase chain reaction is used as the reliable diagnostic platform and antigen/antibody detection immunoassays are playing the role of screening tests for early detection and prognosis in COVID-19 treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink